PepGen (PEPG) - Market Cap to Earnings
The price indicator on the PepGen Inc. (PEPG) chart demonstrates the dynamics of an asset whose environmental impact is limited to waste disposal in third-party laboratories, with a coefficient of -5.00. The biotech firm is developing an EDO system for the efficient transport of drugs into muscle tissues for Duchenne muscular dystrophy. Currently, PepGen Inc. (PEPG) relies on investment income while awaiting profits from the release of oligonucleotide agents for the therapy of severe muscle pathologies.
Analytical breakdowns for PepGen Inc.
- stock price and consensus target price:
- market capitalization indicators:
- book value of equity indicators:
- company liabilities and liquidity data:
- net income and valuation multiples indicators:
PEPG - Net Profit|Future Profit PepGen Inc.|PEPG - Price to Earnings Ratio|Market Cap to Projected Earnings PepGen Corp|PEPG - Price/Earnings to Growth Ratio|Company Value to Operating Income Before Depreciation Ratio PepGen Inc.|PEPG - Operating profit EBITDA|Net earnings per one share for the last twelve months PepGen|PEPG - Earnings per share for the last twelve months|Year-over-year net earnings per share trend for the last twelve months pepgen.com|PEPG - Earnings growth in current year|Net earnings per one share growth forecast for next year PepGen Inc.
General company analysis:pepgen.com - PEPG
PepGen Inc. controls the genetic neurology niche through its EDO platform, which ensures inelastic demand for muscular dystrophy therapies. This price-to-earnings ratio digitizes the market value of one dollar of net income, allowing investors to identify asset overheating and avoid fatal drawdowns by analyzing fair valuation through the dynamics of this chart.
Key competitors
biogen.com - Market Cap to Net Income|P/E Multiple NBIX|RGC - Market Cap to Earnings|Price to Earnings Ratio Axsome Therapeutics Inc AXSM|ACAD (ACADIA Corp) - Market Cap to Net Income|Xenon Pharmaceuticals - P/E Multiple|Market Cap to Net Income Ratio vikingtherapeutics.com (VKTX)|SUPN: P/E Multiple|Market Cap to Earnings Catalyst Pharma (CPRX)|Price to Earnings Ratio Denali Therapeutics Inc|Price to Earnings Multiple HRMY (Harmony Corp)|Price to Earnings Ratio BHVN (Biohaven Ltd.)|AMLX (amylyx.com) - Company Value to Net Income|P/E Multiple TRVI (Trevi Therapeutics, Inc.)|Business Payback Period Praxis Precision Medicines Inc (PRAX)|AVXL - Price to Earnings Ratio|CBLL (CeriBell EEG) - Price to Earnings Multiple|PRTA: P/E Multiple|Price to Earnings Ratio Alector|Price to Earnings Ratio ANNX|Omeros Corp. (OMER) - Business Payback Period|Price to Earnings Ratio Neurogene Corp (NGNE)|ACIU: Market Cap to Net Income|P/E Multiple VYGR (Voyager Therapeutics)|neumoratx.com (NMRA) - Market Cap to Earnings|SCLX - Price to Earnings Ratio|Market Cap to Net Income TVGN|ACOG: P/E Multiple|Market Cap to Net Income Ratio Cognition Therapeutics Inc. CGTX|Price to Earnings Ratio Inhibikase Therapeutics|Price to Earnings Multiple SAVA (cassavasciences.com)|P/E Multiple ASRT|COYA - Market Cap to Earnings|Vistagen - Price to Earnings Ratio|P/E Multiple Ovid Therapeutics Inc OVID|ABOS - Price to Earnings Ratio|Company Value to Net Income CRVO (cervomed.com)|alteritytherapeutics.com (ATHE) - Price to Earnings Ratio|Market Cap to Earnings Clene (CLNN)|Price to Earnings Ratio Jupiter Neurosciences|Relmada Corp - Market Cap to Net Income|P/E Multiple ANVS|GRCE - Market Cap to Earnings|Price to Earnings Ratio Firefly Neuroscience AIFF|KLTO (ANEW Medical) - Market Cap to Net Income|NeuroSense Therapeutics, Ltd. - P/E Multiple|Market Cap to Net Income Ratio Reviva Pharmaceuticals, Inc. (RVPH)|MTVA: P/E Multiple|Market Cap to Earnings neuraxis.com (NRXS)|Price to Earnings Ratio Helius Medical Technologies, Inc.|Price to Earnings Multiple PASG (Passage Bio Corp)|Price to Earnings Ratio NEUP (Neuphoria Therapeutics Inc.)|NERV (Minerva) - Company Value to Net Income|P/E Multiple ATHA (Athira Pharma, Inc.)|Business Payback Period addextherapeutics.com (ADXN)|ALZN - Price to Earnings Ratio|CYCN (Cyclerion Therapeutics) - Price to Earnings Multiple|PTIX: P/E Multiple|Price to Earnings Ratio Pasithea Therapeutics Corp.|Price to Earnings Ratio CRGT|avenuetx.com (ATXI) - Business Payback Period|Price to Earnings Ratio BrainStorm Cell Therapeutics (BCLI)|CARA: Market Cap to Net Income|P/E Multiple CHRO (Chromocell Therapeutics Corporation)|Eliem Therapeutics, Inc. (ELYM) - Market Cap to Earnings|ITCI - Price to Earnings Ratio|Market Cap to Net Income LBPH|MRNS: P/E Multiple|Market Cap to Net Income Ratio NKGen Biotech Inc NKGN|Price to Earnings Ratio NeuroBo|Price to Earnings Multiple SAGE (Sage Therapeutics Inc)|P/E Multiple SNPX|TRVN - Market Cap to Earnings|Vigil Neuroscience, Inc. - Price to Earnings Ratio|P/E Multiple anewmeds.com WENA|CERE - Price to Earnings Ratio
